Regenerative medicine

Regenerative medicine Agency Consulting firm Experts Specialists Consultancy

Develop new regenerative biotherapeutics and optimize your innovation potential in the healthcare market

Stemming from a long experience in healthcare, Alcimed has been exploring the regenerative medicine market across a variety of projects on stem cells and tissue engineering, assisting clients in maximizing the potential of regenerative biotherapeutics, while researching the market and seizing its potential.

    Tell us about your uncharted territory

    You have a project and want to discuss it with our explorers, write us!

    One of our explorers will contact you shortly.

    They trust us


    The challenges related to regenerative medicine

    The regenerative medicine industry is rapidly evolving, presenting a range of potential issues that require consideration. To overcome these obstacles, companies are required more and more to sharpen their regenerative biotherapeutics strategy, via innovation and a deep understanding of the market. New innovative approaches ought to consider the challenges associated with using embryonic stem cells, engineered tissue, embryonic stem cells, cell therapy, bone marrow, in research projects, and in clinical trials.

    Key challenges that need to be addressed include ensuring the safety and efficacy, overcoming immune rejection of transplanted cells or tissues and developing scalable manufacturing processes for therapy production. Furthermore, controlling stem cell differentiation and integration into target organs, addressing ethical and regulatory issues around human stem cell use and genetic modification, and ensuring access to a regenerative therapy and treatment reimbursement remain key priorities for healthcare companies.

    Alcimed’s team of explorers has been delving deeper into these challenges, examining their development and meaning for the industry.

      Tell us about your uncharted territory

      You have a project and want to discuss it with our explorers, write us!

      One of our explorers will contact you shortly.

      How we support you in your projects related to regenerative medicine 

      Alcimed has been supporting different clients on projects related to stem-cells, tissue engineering and regenerative medicine, from research to clinical stages, and from science to marketing.

      Thanks to our wide range of clients including pharmas, biotechs, research centers, professional associations, national and European institutions, as well as our exploration of various geographical fields and project types, we have gained a comprehensive and global understanding of the issues surrounding regenerative medicine.

      Our projects encompass a wide variety of topics within regenerative medicine, including new technologies and therapeutic approaches, fundraising, preparing for the launch of innovative products, understanding local needs in terms of healthcare and patient care pathways. Our explorations have helped clients assessing market and licensing opportunities, addressing market access, understanding pricing and reimbursement pathways and monitoring regulatory developments. Alcimed team has also provided operational support such as optimizing patient care pathways and identifying patients in need.

      Examples of recent projects carried out for our clients in regenerative medicine

      • Conducting a market study for the osteoarthritis treatment market in Europe

        In this project, our team conducted an in-depth exploration of the European osteoarthritis treatment market, to support a leading pharmaceutical player’s offer and positioning with their new regenerative medicine technique.

        The investigation entailed the study of the competition, the available products and their prices, and the main treatments under development. Identification of direct and indirect competitors helped understand the potential opportunities and risks in the osteoarthritis treatment market, while being aware of key trends in the market.

        Through the support of a tailored methodology, the project allowed to facilitate the product positioning within the market and the key market figures collected helped our client build a business plan and embark new investors in their project.

      • Creating a pitch report for investors on a project about regenerative medicine

        Alcimed accompanied a healthcare stakeholder in building a set of solid arguments to convince investors involved in regenerative medicine, more specifically in organs’ transplants.

        To do so, the Alcimed team engaged in the identification of the needs in terms of number of transplanted organs and organ requirements. While checking competing technologies, and players competing for the same technologies. The project provided an in-depth analysis of the associated risk factors, from both an ethical and regulatory perspective.

        Results provided a strong case for investors, by providing information on the existing competition level, market potential, and potential risks.

      • Deciphering the regulatory panorama for induced pluripotent stem cells

        In order to support their long-term strategy, Alcimed has accompanied a research institute in understanding the potential of Induced Pluripotent Stemcells Cells (IPSC) across geographies.

        The project consisted in the analysis of the healthcare needs linked to IPSC, in terms of organ donation shortages, as well as the evaluation of the country-specific legal and ethical constraints in the research and development activities around IPSC.

        The project led to an understanding of the larger regulatory panorama of IPSC R&D within selected geographies, allowing to gain clarity on the key requirements in this area of research.

      • Assessing the opportunity of a cellular therapy product

        In this project, our client, a leading healthcare player, required support in evaluating the business potential of a cellular therapy product for cartilage regeneration in a EU-country.

        This involved analysing the current patient management practices, assessing the product’s level of acceptance among orthopedic surgeons, estimating the market size, and overcoming previous challenges in market estimation.

        Ultimately, Alcimed’s support allowed to determine the business opportunity of the product, serving as a critical decision-making and negotiation tool for establishing a potential distribution partnership.

      • Identification and evaluation of the most innovative technologies within the field of stem cells for a pharmaceutical company

        Our team worked with a pharmaceutical client to identify start-ups in the field of stem cells to partner with them for further development.

        To do so, we analyzed the global field of endogenous and autologous stem cell therapy and identified key emerging technologies. First, we carried out an in-depth analysis of the clinical trials and patents landscape for both fields of stem cell therapies. Then, we refined focus areas and identified current trends of innovative technologies through a literature analysis and a monitoring of social media (Medtrack, Espacenet,, Scopus, Pubmed, Twitter).

        We therefore analyzed the current trends in the field of endogenous and autologous stem cells, identified current technologies and relevant companies in both fields and reviewed the most promising ones for a potential partnership with our client.

      You have a project?

        Tell us about your uncharted territory

        You have a project and want to discuss it with our explorers, write us!

        One of our explorers will contact you shortly.

        To go further